SNPX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.73%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Synaptogenix Insider Trading History Chart

Synaptogenix Share Price & Price History

^$2.27

▼ -0.1 (-4.22%)

As of 04/3/2025 04:57 PM ET

Days: 30 | 90 | 365

Synaptogenix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/16/2022	Daniel L. Alkon	Insider	Sell	787	$29.25	$23,019.75	1,421
12/16/2022	William S Singer	Director	Sell	1,080	$29.25	$31,590.00	1,320

SEC Filings (Institutional Ownership Changes) for Synaptogenix (NASDAQ:SNPX)

10.34% of Synaptogenix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Synaptogenix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/12/2025	Geode Capital Management LLC	10,844	$39K	0.0%	N/A	0.797%
2/3/2023	Cannell & Co.	30,000	$35K	0.0%	-60.6%	0.413%
1/11/2023	Platform Technology Partners	25,138	$29K	0.0%	+56.8%	0.346%
8/12/2022	Ikarian Capital LLC	121,191	$0.61M	0.1%	-20.9%	1.772%
5/3/2022	Platform Technology Partners	16,032	$0.12M	0.1%	-25.0%	0.235%
2/14/2022	Diametric Capital LP	30,521	$0.26M	0.2%	-17.2%	0.457%
2/7/2022	Orion Capital Management LLC	4,000	$34K	0.0%	N/A	0.060%
2/1/2022	Platform Technology Partners	21,375	$0.18M	0.1%	-34.2%	0.320%
9/17/2021	Virtu Financial LLC	14,259	$0.14M	0.0%	N/A	0.232%
8/18/2021	Ikarian Capital LLC	300,000	$2.96M	0.2%	N/A	4.968%
8/17/2021	Worth Venture Partners LLC	73,909	$0.64M	0.2%	N/A	1.224%
8/17/2021	Boothbay Fund Management LLC	34,079	$0.34M	0.0%	N/A	0.564%
8/16/2021	Diametric Capital LP	21,901	$0.22M	0.2%	N/A	0.363%
8/12/2021	AIGH Capital Management LLC	316,945	$2.83M	0.5%	N/A	5.248%
8/10/2021	CM Management LLC	10,000	$99K	0.1%	N/A	0.166%
8/5/2021	Platform Technology Partners	32,500	$0.32M	0.1%	N/A	0.538%

Data available starting January 2016

See Full Table

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.

Today's Range

Now: $2.27

$2.27

$2.36

50 Day Range

MA: $2.87

$2.27

$3.53

52 Week Range

Now: $2.27

$2.15

$6.22

Volume

6,153 shs

Average Volume

30,908 shs

Market Capitalization

$3.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1